Global neurology devices market is expected to reach USD 10.8 billion by 2022, according to a new report by Grand View Research, Inc. This expected growth in demand can be ascribed to growing need for development of different neurostimulation techniques with efficient and accurate algorithms for treatment of several CNS associated disorders.
Rise
in incidence of cerebral stroke and other severe disorders such as Alzheimer’s
disease, epilepsy, and Parkinsonism is expected to fuel demand of neurology
devices thereby driving industry growth. According to National Institute of
Neurological Disorders and Stroke (NINDS), approximately 50 million Americans
are affected due to these disorders leading to high economic & disease
costs burden for medical expenses coupled with loss of productivity. The
industry is expected to witness a considerable increase in demand for CNS
related therapeutic procedures over the forecast period.
For Full Research Report On Neurology Devices Market Visit Here:
https://www.grandviewresearch.com/industry-analysis/neurology-devices-market
Further key
findings from the study suggest:
- Neurostimulation devices
accounted for over 50% of the revenue generated in the market for 2014. This
large share can be attributed to the growing number of chronic CNS
disorders, a globally ageing population and development of minimally
invasive neurological and faster acting stimulation devices that attract
higher market usage and penetration in the neurology devices market.
- Neurosurgery segment
including ultrasonic aspirators, stereotactic systems, neuroendoscopes,
and aneurysm clips are expected to witness considerable growth over the
forecast period due to their essential nature of use in tumor removal and
brain cell damage repair surgeries.
- North America dominated the
market in 2014, with revenue estimated at over USD 2,400 million. Presence
of sophisticated healthcare infrastructure, favorable government
initiatives pertaining to pharmaceutical R&D, cancer research,
neurological R&D investment, and the presence of a considerably large
CNS disorder patient base are some drivers of this market.
- Asia Pacific is expected to
witness lucrative CAGR of over 8.0% from 2015 to 2022 due to the presence
of high-unmet medical needs coupled with rapidly rising healthcare R&D
investment, and growing medical expenditures in emerging economies such as
India and China. Supportive government initiatives pertaining to
increasing investments by manufacturers and governments in
neuro-informatics and high untapped market opportunities are the important
factors accounting for the expected growth of market in this region over
the forecast period.
- Key participants of the
neurology devices market include Johnson and Johnson, B.Braun Melsungen
AG, Boston Scientific Corporation, St. Jude Medical Inc Covidien PLC,
Medtronic Inc., Johnson & Johnson, Magstim Co Ltd., W.L. Gore &
Associates Inc., Integra Life Sciences Holdings Corp., Stryker Corp.
- Market participants are
involved in R&D for development of advanced stimulation and
neuromodulation techniques with minimally invasive procedures that are
more preferable to the patients. Furthermore, collaborations with
university as well as non-university based institutes that are engaged in
neuroscience research are expected to boost sector growth in the coming
years.
Request a Sample Copy of the Report @
https://www.grandviewresearch.com/industry-analysis/neurology-devices-market/request/rs1
Grand View Research has segmented
neurology devices market on the basis of product, method, application, and
region:
Global Neurology
Devices Product Outlook (Market Revenue in USD Million, 2012 - 2022 )
- Neurostimulation
- Spinal Cord Stimulation
- Spinal Cord Stimulation
- Deep Brain Stimulation
- Sacral Nerve Stimulation
- Vagus Nerve Stimulation
- Gastric Electric
Stimulation
- Interventional Neurology
- Aneurysm Coiling and
Embolization
- Embolic Coils
- Flow Diversion Devices
- Liquid Embolic Reagents
- Neurovascular Catheters
- Micro Catheters
- Micro Guidewires
- Cerebral Balloon
Angioplasty &Stents
- Carotid Artery Stents
- Filter Devices
- Balloon Occlusion Devices
- Neurothromobectomy
- Clot Retrievers
- Suction Aspiration Devices
- Snare Devices
- CSF Management Devices
- Cerebral Shunts
- Cerebral External Drainage
- Neurosurgery Devices
- Ultrasonic Aspirators
- Stereotactic Systems
- Neuroendoscopes
- Aneurysm Clips
Global Neurology
Devices Regional Outlook (Revenue, USD Million, 2012 - 2022)
- North America
- Europe
- Asia Pacific
- RoW
About Grand View Research
Grand View Research, Inc. is a U.S. based
market research and consulting company, registered in the State of California
and headquartered in San Francisco. The company provides syndicated research
reports, customized research reports, and consulting services. To help clients
make informed business decisions, we offer market intelligence studies ensuring
relevant and fact-based research across a range of industries, from technology
to chemicals, materials and healthcare.
For more info visit @ https://www.grandviewresearch.com
No comments:
Post a Comment